ANGANY
Created in 2017
Up & running (A)
Existing signals show a regular activitySocial networks
2,000 2,000Activities
Technologies
Entity types
Location
873 Rue Saint-Jean #200, Québec, QC G1R 1R2, Canada
Québec
Canada
Employees
Scale: 11-50
Estimated: 19
Engaged catalyst
1
0 0Added in Motherbase
1 year, 10 months ago
Value proposition
Biologics of a New Generation to Treat Allergy
ANGANY is a private, early clinical stage pharmaceutical company, based in Lévis, QC, Canada. ANGANY has tackled the specific challenges of allergy to invent a novel class of biologics. ANGANY has developed an exclusive therapeutic platform based on synthetic biology: the eBioparticle TM, a self-adjuvant vector bringing novel features of safety and potent immunomodulation to thwart allergy.
Home | ANGANY
ANGANY proposes a new generation of allergy therapeutics aimed at helping allergic people build their own protective response against the pecise cause of their allergy.
https://angany.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 | SATT Aquitaine Science Transfert | Other 10 Mar 2025 | | |